Evidence map›Paper›PMID 32274499›Full record

ArticleThe Journal of infectious diseases2020

Genital Shedding of Human Immunodeficiency Virus Type-1 (HIV) When Antiretroviral Therapy Suppresses HIV Replication in the Plasma.

Marta Bull, Caroline Mitchell, Jaime Soria, Sheila Styrchak, Corey Williams, Joan Dragavon, Kevin J Ryan, Edward Acosta, Frankline Onchiri, Robert W Coombs and 3 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.1field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Genome sequences of human anelloviruses in theMicrobiology resource announcements · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Marta BullSeattle Children's Research Institute, Seattle, Washington, USA.
Caroline MitchellDepartment of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.
Jaime SoriaInfectious Diseases Department, Hospital Nacional Dos de Mayo, Universidad Nacional Mayor de San Marcos, Lima, Peru.
Sheila StyrchakSeattle Children's Research Institute, Seattle, Washington, USA.
Corey WilliamsSeattle Children's Research Institute, Seattle, Washington, USA.
Joan DragavonDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Kevin J RyanSchool of Medicine, University of Alabama, Birmingham, Alabama, USA.
Edward AcostaSchool of Medicine, University of Alabama, Birmingham, Alabama, USA.
Frankline OnchiriCore for Biomedical Statistics, Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Robert W CoombsDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Alberto La RosaAsociaciòn Civil Impacta Salud y Educación, Lima, Peru, and.
Eduardo TiconaInfectious Diseases Department, Hospital Nacional Dos de Mayo, Universidad Nacional Mayor de San Marcos, Lima, Peru.
Lisa M FrenkelSeattle Children's Research Institute, Seattle, Washington, USA.
University of Washington · USNational University of San Marcos · PEUniversity of Alabama at Birmingham · USAsociación Civil Impacta Salud y Educación · PESeattle Institute for Biomedical and Clinical Research · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Mechanism/predictors of genital/rectal HIV shedding during ART w/plasma <50c/mLR01AI071212 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI FRENKEL, LISA M · 2006 to 2010
$2.4M
HIV-1 evolution in the female genital tract and trafficking to the bloodR01AI091550 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI FRENKEL, LISA M · 2011 to 2015
$1.9M
NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI071212NIAID NIH HHS R01 AI091550NIAID NIH HHS U01 AI068636NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI106701
6 · The paper itself

Abstract

backgroundDuring antiretroviral treatment (ART) with plasma HIV RNA below the limit of quantification, HIV RNA can be detected in genital or rectal secretions, termed discordant shedding (DS). We hypothesized that proliferating cells produce virions without HIV replication.

methodsART-naive Peruvians initiating ART were observed for DS over 2 years. HIV env and pol genomes were amplified from DS. Antiretrovirals and cytokines/chemokines concentrations were compared at DS and control time points.

resultsEighty-two participants had ART suppression. DS was detected in 24/82 (29%) participants: 13/253 (5%) cervicovaginal lavages, 20/322 (6%) seminal plasmas, and 6/85 (7%) rectal secretions. HIV RNA in DS specimens was near the limit of quantification and not reproducible. HIV DNA was detected in 6/13 (46%) DS cervicovaginal lavages at low levels. Following DNase treatment, 5/39 DS specimens yielded HIV sequences, all without increased genetic distances. Women with and without DS had similar plasma antiretroviral levels and DS in 1 woman was associated with inflammation.

conclusionsHIV RNA and DNA sequences and therapeutic antiretroviral plasma levels did not support HIV replication as the cause of DS from the genital tract. Rather, our findings infer that HIV RNA is shed due to proliferation of infected cells with virion production.

Indexed as

Virus SheddingAdultAnti-HIV AgentsBodily SecretionsCervix UteriCytokinesDNA, ViralFemaleGenes, envGenes, polHIV-1HIV InfectionsHumansMaleProspective StudiesRectumAnti-HIV AgentsCytokinesDNA, ViralRNA, Viraldrug levelsgenital HIV sheddingHIV phylogeneticsinflammation

Identifiers

PMID32274499
PMCPMC7399698
OpenAlexW3015489715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.